Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Feb 7, 2024
- Accession no.
- 0001447362-24-000010
- Filed
- Feb 7, 2024
- Trade date
- Feb 5-6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions. Open-market sales total $493.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | Common Stock | SSaleDisposed | −2,751 | $22.74F2 | −$62,557.74 | 61,944 | Indirect | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −2,963 | $22.74F2 | −$67,378.62 | 38,870 | Indirect | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −2,964 | $22.74F2 | −$67,401.36 | 38,885 | Indirect | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −863 | $23.42F6 | −$20,211.46 | 61,081 | Indirect | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −930 | $23.42F6 | −$21,780.6 | 37,940 | Indirect | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −931 | $23.42F6 | −$21,804.02 | 37,954 | Indirect | |
| Feb 6, 2024 | Common Stock | SSaleDisposed | −3,121 | $23.63F7 | −$73,749.23 | 57,960 | Indirect | |
| Feb 6, 2024 | Common Stock | SSaleDisposed | −3,362 | $23.63F7 | −$79,444.06 | 34,578 | Indirect | |
| Feb 6, 2024 | Common Stock | SSaleDisposed | −3,364 | $23.63F7 | −$79,491.32 | 34,590 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $22.33 to $23.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.